Virology: Leprosy drug treats SARS-CoV-2 in a hamster model
Nature
2021년3월16일
The drug clofamizine, which is currently used to treat leprosy, is effective against SARS-CoV-2 infection in human cells and a hamster model, reports a Nature paper. Clofamizine can be taken orally and has a comparatively low manufacturing cost, which could make it a potentially attractive candidate for treatment of patients with COVID-19.
Sumit Chanda and colleagues studied the effectiveness of the drug clofamizine, which has been approved for use by the US Food and Drug Administration, against coronaviruses. The authors found that the drug was able to reduce the replication of two coronaviruses (SARS-CoV-2 and MERS-CoV) in human and monkey cell lines and human lung tissue. In an analysis of the antiviral action of the drug, they observed that it targets multiple steps in the replication of SARS-CoV-2, including interfering with the cell fusion process and the activity of the viral helicase enzyme.
In a hamster model of SARS-CoV-2 infection, administration of clofamizine prior to or after exposure to the virus significantly reduced the number of virus particles found in the lungs. When co-administered with remdesivir, the two drugs acted synergistically in reducing viral replication. A low dose of remdesivir combined with clofamizine significantly improved viral control in the hamster model.
The authors suggest that clofamizine could be an attractive candidate for outpatient treatment of SARS-CoV-2. Clinical evaluation is now required to establish its potential as a treatment option.
The paper is available at the following link: https://www.nature.com/articles/s41586-021-03431-4
doi: 10.1038/s41586-021-03431-4
리서치 하이라이트
-
6월30일
Microbiology: Transmission of gastrointestinal viruses in salivaNature
-
6월29일
COVID-19: Assessing instances of long COVID in UK health dataNature Communications
-
6월24일
Sport science: New wearable sensor to measure neck strain may detect potential concussionScientific Reports
-
6월23일
Scientific community: Women credited less than men in scientific paper authorshipNature
-
6월17일
Health technology: New cost-effective smartphone test for middle ear functionCommunications Medicine
-
6월16일
Cancer: Signatures of structural genomic variation in cancerNature